Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
44 /100
MEDIUM RISK
Score updated Oct 13, 2026

TNXP — Tonix Pharmaceuticals Holding Corp. Dilution Risk Tracker

Track TNXP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TNXP — Get alerts when the score changes →

As of October 13, 2026, Tonix Pharmaceuticals Holding Corp. (TNXP) has a DilutionWatch DilutionScore of 44/100, rated MEDIUM dilution risk. Tonix Pharmaceuticals Holding Corp. has a market capitalization of $113.88M, 17.15M shares outstanding, 82 institutional holders tracked. Stored dilution-related fields include 641.3K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
25
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 30%
🔁 Convertible Conversion model 60%
• Major convertible overhang: 37% potential dilution
• Convertible risk score very high (85/100)
🔔 Track TNXP — Get forecast alerts →

Market Data

Market Cap$113.88M
Shares Outstanding17.15M
Float15.92M
Cash$192.81M
Debt$7.49M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore44/100DilutionWatch score record
Shares Outstanding17.15MVerified float table or market cache
Public Float15.92MVerified float table or market cache
Market Cap$113.88MMarket data cache
Cash Runway21.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants641.3KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 47.2% shares (2026Q1 vs prior)
82 institutional holders · 5.76M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 1.04M shares
#2 BlackRock, Inc. 968.2K shares
#3 CITADEL ADVISORS LLC 511.8K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.94M
Days to Cover5.9
% of Float18.5%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-10
xbrl XBRL CONVERTIBLE 2014-03-28
4 INSIDER TRANSACTION 2026-04-01
4 INSIDER TRANSACTION 2026-03-18
4 INSIDER TRANSACTION 2026-02-26
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual TNXP Dilution Snapshot

Tonix Pharmaceuticals Holding Corp. (TNXP) has a DilutionScore of 44/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

TNXP's DilutionScore is currently 44/100 (Medium risk), with 6 score changes tracked over 89 days. The score deteriorated from 48/100 (Medium risk).

Period Score Risk Level Duration
Sep 28 – Oct 13, 202644/100MEDIUM16 days
Sep 16 – Sep 27, 202648/100MEDIUM12 days
Aug 30 – Sep 15, 202649/100MEDIUM17 days
Aug 22 – Aug 29, 202654/100HIGH8 days
Aug 14 – Aug 21, 202646/100MEDIUM7 days
Jul 17 – Aug 13, 202654/100HIGH28 days
Jul 16, 202653/100HIGH1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

TNXP shares outstanding have increased 24.7% from 12.79M (Mar 2026) to 15.94M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 16, 202615.94M15.92M▲ 0.02%
May 14, 202615.94M15.91M▲ 16.30%
May 13, 202615.94M13.68M▲ 2.25%
Apr 07, 202614.21M13.38M▼ 0.04%
Mar 22, 202613.41M13.39M▼ 0.11%
Mar 14, 202612.79M13.40M▲ 13.83%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track TNXP Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment TNXP files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking TNXP — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TNXP
TNXP FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.